๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-04-28

Sustained Inflation and Chest Compression vs 3:1 C:V Ratio in Asphyxiated Newborns (NCT06577818)

Sustained Inflation and Chest Compression Versus 3:1 Chest Compression to Ventilation Ratio During Cardiopulmonary Resuscitation of Asphyxiated Newborns - a Multi-centre, International Cluster Randomized Control Trial

๐ŸŸก Not Yet Recruiting Observational / Diagnostic ๐Ÿฉบ Clinical Procedure Protocol Sponsor: University of Alberta

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

Newborn infants who require cardiopulmonary resuscitation at birth receive chest compression using a 3-Compression to 1-Ventilation (3:1 C:V) ratio. However, the optimal chest compression technique during cardiopulmonary resuscitation is uncertain and identified as a critical gap in evidence. The International Consensus Statement advises to use the 3:1 C:V ratio based on animal studies, and states that there are no clinical trials to support this approach and called for more research. There continues to be uncertainty about the optimal chest compression technique during cardiopulmonary resuscitation. This trial will compare if in newborn infants with cardiac arrest in the delivery room does providing CC+SI (a new chest compression technique) compared to 3:1 C:V decreases the incidence of all mortality within the initial hospital stay. This will be a multi-centre international cluster randomized trial.

Who can join: Review the eligibility criteria below.

Location: Royal Alexandra Hospital โ€” Edmonton

Age range: Not specified to 40 Minutes

๐Ÿงช Interventions in This Study

  • CC+SI (Chest compression during sustained inflation) (PROCEDURE)
  • 3:1 C:V (3:1 Compression:Ventilation ratio) (PROCEDURE)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Royal Alexandra Hospital โ€” Edmonton,

๐Ÿ“ž Contact the Study Coordinator

Phone: (780) 613-5237

Email: caroline.fray@albertahealthservices.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Cardiac Arrest clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—